Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

PURPOSE: Increased prostate cancer risk has been reported for BRCA mutation carriers but BRCA-associated clinicopathologic features have not been clearly defined. EXPERIMENTAL DESIGN: We determined BRCA mutation prevalence in 832 Ashkenazi Jewish (AJ) men diagnosed with localized prostate cancer bet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gallagher, David J., Gaudet, Mia M., Pal, Prodipto, Kirchhoff, Tomas, Balistreri, Lisa, Vora, Kinjal, Bhatia, Jasmine, Stadler, Zsofia, Fine, Samson W., Reuter, Victor, Zelefsky, Michael, Morris, Michael J., Scher, Howard I., Klein, Robert J., Norton, Larry, Eastham, James, Scardino, Peter, Robson, Mark E., Offit, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3713614/
https://ncbi.nlm.nih.gov/pubmed/20215531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2871
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares